Sign in
4

Changes in Ownership

EXELIXIS, INC. Filed Acc 0000939767-21-000007

EVP, Scientific Strategy & CSO sold 65,000 shares at $22.08 ($1,435,200)

  • EVP, Scientific Strategy & CSO acquired 65,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lamb Peter · EVP, Scientific Strategy & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-01 Exercise or conversion : show line 1 in the form +65,000 $1.70 $110,500 348,124 D
2021-02-01 Sale : show line 2 in the form −65,000 $22.08 $1,435,200 283,124 D
Open-market sales · 65,000 sh · avg $22.08 · $1,435,200

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-01 Exercise or conversion : show line 3 in the form Option (right to buy) −65,000 $1.70 2021-09-18 65,000 125,000 D
Loading xslF345X03/wf-form4_161240023597689.xml…